The article dives into the golden age of biotechnology and what’s the drive behind its current rapid evolution. Carsten Thiel has been involved in this industry to address human fundamentals of living a healthier life, living longer, and free of disease.

Carsten Thiel is an authority in biotechnology having spent a good number of years in the industry. He believes that the field has entered its golden age and the future holds a lot of promise. Answers to pertinent human concerns like living disease-free lives are sure to be addressed during this period.

As the article addresses on why there’s rapid acceleration in innovation, they believe it’s due to lowered cost and automation.

Automation is being implemented by many industries in today’s age. They mention the use of automation helps with cost and efficiency. An example was made with X-ray crystallography. It use to take 10 years to solve a complex of two proteins interacting at atomic resolution. A big biotech company can now do 400 year.

In the 1980s and 1990s, the industry went through a revolution of using therapeutic proteins to target diseases. Carsten Thiel is in industry that’s engineered more than a dozen different modalities to use. These tools are meant to interdict biological targets.

The good news is we’re now getting more precise and laser-focused. There’ll be regenerative cell therapies, gene therapy, viruses, and nucleic acids are some examples of new modalities that can overcome barriers to treating disease. Technology has become so advanced in this field, that they’re finding cures for diseases. They’re moving on from finding treatments to finding cures. This includes hepatitis C, certain types of cancers, and curative strategies for HIV. See This Page for additional information.

Biotechnology has a bright future which shouldn’t slow down until a couple of decades.


Follow him on


Comments are closed, but trackbacks and pingbacks are open.